理邦儀器(300206.SZ):子公司博識診斷變更經營範圍
格隆匯 8 月 3日丨理邦儀器(300206.SZ)公佈,公司於近日接到控股子公司深圳博識診斷技術有限公司(“博識診斷”)的通知,因博識診斷業務發展需要,其變更了經營範圍,並根據《中華人民共和國公司法》等法律法規相關規定,對《深圳博識診斷技術有限公司章程》進行了修訂。此次變更的經營範圍已經深圳市市場監督管理局核准,相關工商變更登記備案手續也已辦理完畢,並取得新的《營業執照》,具體情況如下:
變更前內容:經營範圍:體外診斷儀器及試劑的研發和相關技術服務。生產和銷售醫療器械(第二類醫療器械、第二類體外診斷試劑、第三類醫療器械、第三類體外診斷試劑),醫療器械(新型診斷試劑)的開發、生產。
變更後內容:經營範圍:體外診斷儀器及試劑的研發和相關技術服務。生產和銷售醫療器械(第一類醫療器械、第二類醫療器械、第二類體外診斷試劑、第三類醫療器械、第三類體外診斷試劑),醫療器械(新型診斷試劑)的開發、生產;電子產品、通訊產品、信息系統、計算機軟件、獸用器械(含獸用醫療器械)、家用器械、消毒類產品的研發、生產、批發、零售、進出口、售後服務及相關配套業務;從事醫療器械的技術開發、技術諮詢、技術轉讓、技術服務、技術進出口業務(不涉及外商投資准入特別管理措施);從事工業設計、計算機軟件設計開發與諮詢(不含限制項目);電子產品、通訊產品、醫療器械的檢測、諮詢服務。(涉及配套許可證管理、專項規定管理的商品按國家有關規定處理)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.